Quilizumab

quilizumab · Genentech, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Quilizumab, covering 2016-11-02 to 2016-11-02. Get the full timeline:

Most recent: Clinical Trial Update: A Study of Quilizumab Versus Placebo in Patients With Refractory Chronic Spontaneous Urticaria [Phase 2]